Kenyan Parliament Debates Ammendment to Patent Law to Restrict Access to Generic Drugs

July 26, 2006

Proposed amendments to the law, if passed, will force the Kenyan Government to purchase patented drugs and restrict access to generics.

Treatment for endemic conditions such as Aids and for infectious diseases including malaria and tuberculosis are likely to soar to three to ten times current prices. Read the rest of this entry »


US Patent Office Examination Reform Likely

July 26, 2006

The US Deputy Commissioner for Patent Examination Policy Jay P. Lucas announced in a speech at the George
Mason University Law School last week that the final rules concerning Continuations and claim number limitations would be published at the end of the year. Read the rest of this entry »


Retraction

July 20, 2006

In a blog-entry published back in February 2, 2006, now deleted, I reported a high profile labor dispute, specifically that Patent Attorney Itzhak Rachailovich (now associated with Factor – Patent Attorneys) was suing his former employer Dr.Shlomo Cohen and Dr. Shlomo Cohen & Partners for redundancy benefits, and briefly described the main claims of both sides as reported in the papers.

In that blog-entry I reported that Itzhak Rachailovitch was “formerly head of the intellectual property department at Dr. Shlomo Cohen & Co.”. This was a typographical error. During his employment at Dr. Shlomo Cohen & Partners, Mr. Rachailovich’s responsibilities there were confined to Patent work only. I retract the original statement and apologize to Dr. Shlomo Cohen for any damage to his reputation that the erroneous statement regarding the scope of Mr. Rachailovich’s responsibilities may have caused him and his firm.


USPTO Announces Accelerated Review Option

July 11, 2006

The United States Patent and Trademark Office (USPTO) is publishing “accelerated examination” procedures designed to enable patent applicants to obtain a final decision on whether their application for a patent will be granted or denied within 12 months of filing. Read the rest of this entry »


Removing Sex and Bad Language from Films is a Copyright Infringement

July 10, 2006

An appeals judge has ruled that editing movies to delete objectionable language, sex and violence is an “illegitimate business” that hurts Hollywood studios and directors who own the movie rights. Read the rest of this entry »


Israel Patent Office Raises Fees

July 4, 2006

On July 1, 2006, the Israel Patent Office fees underwent their biannual adjustment in accordance with the cost of living.

All fees have gone up around 1%. The basic fee for Read the rest of this entry »


Teva Attacks Eli Lilly’s Patents for Evista

July 2, 2006

Three drugs: Fosamax, Evista and Actonel dominate the osteoporosis treatment market, and a fourth drug, Boniva, recently became available.

Teva Pharmaceutical successfully fought Read the rest of this entry »


Teva to Produce Generic Version of Zoloft

July 2, 2006

Teva has now received final approval to market a generic version of Pfizer’s Antidepressant, Zoloft®. The drug has 3 billion dollars of sales annually, and has been around for 14 years. Teva’s version will be available within weeks. 

Zoloft® (sertraline HCl) is a selective serotonin Read the rest of this entry »


Lencor and Lengo Trademarks Rejected as Potentially Misleading the Public

July 2, 2006

In a recent ruling, on 25 June 2006, Dr. Meir Noam, the Israel Commissioner of Patents has upheld a decision of the Trademark Department not to allow registration of the marks Lencor and Lengo for domestic appliances. Read the rest of this entry »